Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma
Abstract Necroptosis, a regulated form of necrosis, has emerged as a novel therapeutic strategy that could enhance cancer immunotherapy. However, its role in tumorigenesis is still debated because recent studies have reported both anti- and pro-tumoral effects. Here, we aimed to systematically evalu...
Saved in:
Main Authors: | Thanpisit Lomphithak, Perawatt Akara-amornthum, Keigo Murakami, Masatoshi Hashimoto, Hajime Usubuchi, Erina Iwabuchi, Michiaki Unno, Zhenyu Cai, Hironobu Sasano, Siriporn Jitkaew |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/bed78c056bbb47fc9e8f4e47465203de |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ZBP1 not RIPK1 mediates tumor necroptosis in breast cancer
by: Jin Young Baik, et al.
Published: (2021) -
BEX2 suppresses mitochondrial activity and is required for dormant cancer stem cell maintenance in intrahepatic cholangiocarcinoma
by: Keiichi Tamai, et al.
Published: (2020) -
Mitochondrial Mechanisms of Apoptosis and Necroptosis in Liver Diseases
by: Qingfei Chu, et al.
Published: (2021) -
Dysbiosis in the Human Microbiome of Cholangiocarcinoma
by: Benchen Rao, et al.
Published: (2021) -
Vascular Resection in Perihilar Cholangiocarcinoma
by: Alejandro Serrablo, et al.
Published: (2021)